These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 21644365

  • 1. [Overview of potential oncomarkers for detection of early stages of ovarian cancer].
    Urban P, Bilecová-Rabajdová M, Stefeková Z, Ostró A, Mareková M.
    Klin Onkol; 2011; 24(2):106-11. PubMed ID: 21644365
    [Abstract] [Full Text] [Related]

  • 2. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [Abstract] [Full Text] [Related]

  • 3. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast RC.
    Clin Cancer Res; 2004 May 15; 10(10):3291-300. PubMed ID: 15161682
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A, Ye B.
    Curr Opin Obstet Gynecol; 2008 Feb 15; 20(1):9-13. PubMed ID: 18196999
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Tumor marker in ovarian cancer].
    Komai K, Nishida T.
    Gan To Kagaku Ryoho; 2002 Mar 15; 29(3):481-6. PubMed ID: 11915744
    [Abstract] [Full Text] [Related]

  • 11. Ovarian cancer screening: a look at the evidence.
    Fields MM, Chevlen E.
    Clin J Oncol Nurs; 2006 Feb 15; 10(1):77-81. PubMed ID: 16482731
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 15; 12(2):103-13. PubMed ID: 12582019
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM, Bufe A, Kümper C, Stieber P, Mayr D, Hertlein L, Kirschenhofer A, Friese K, Burges A.
    Arch Gynecol Obstet; 2009 Jul 15; 280(1):71-7. PubMed ID: 19093129
    [Abstract] [Full Text] [Related]

  • 18. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N, Oliva KT, Barker G, Hoffmann P, Reeve S, Smith IA, Quinn MA, Rice GE.
    Proteomics; 2005 Nov 15; 5(17):4625-36. PubMed ID: 16220531
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.